Defect-engineered black titanium dioxide for near-infrared cancer phototherapy: A review
BME Horizon · 2024
DOI: 10.70401/bmeh.2026.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Horizon, 2024. Verfasst von Yun-Fei Pei und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Traditional cancer treatment methodologies, including chemotherapy, surgery, radiotherapy, and immunotherapy, commonly lead to severe adverse reactions. In recent years, innovative treatment modalities, particularly photodynamic therapy (PDT) and photothermal therapy (PTT), have garnered increasing attention due to their enhanced therapeutic levels. Against this background, black TiO2, a new kind of functional material, has become a research emphasis in the domain of cancer treatment. This material exhibits broad spectral absorption and strong near-infrared light penetration, enabling it to efficiently satisfy the optical requirements of both PDT and PTT. This article presents a mini review of PDT, PTT, and their synergistic combination strategies based on black TiO2.
Zitieren
APA
Pei, Y., & Yao, X. (2024). Defect-engineered black titanium dioxide for near-infrared cancer phototherapy: A review. BME Horizon. https://doi.org/10.70401/bmeh.2026.0018
Vancouver
Pei Y, Yao X. Defect-engineered black titanium dioxide for near-infrared cancer phototherapy: A review. BME Horizon. 2024. doi:10.70401/bmeh.2026.0018
BibTeX
@article{Pei2024,
author = {Pei, Yun-Fei and Yao, Xue-Yan},
title = {Defect-engineered black titanium dioxide for near-infrared cancer phototherapy: A review},
journal = {BME Horizon},
year = {2024},
doi = {10.70401/bmeh.2026.0018}
}
EUVIMED